Clinicopathological features and prognostic significance of HER2-low status in breast carcinoma

被引：0
|
作者：
Ilieva-Shipchanova, N. [1 ]
Tashkova, D. [1 ]
Bangieva, E. [1 ]
Miteva, N. [1 ]
机构：
[1] Med Univ Plovdiv, Complex Oncol Ctr Plovdiv, Plovdiv, Bulgaria
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-03
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [21] Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Man Yang
    Jiale Sun
    Liqiong Liu
    Xiangyi Kong
    Dongcai Lin
    Hong Zhou
    Jidong Gao
    Scientific Reports, 13 (1)
  • [22] Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Yang, Man
    Sun, Jiale
    Liu, Liqiong
    Kong, Xiangyi
    Lin, Dongcai
    Zhou, Hong
    Gao, Jidong
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [23] Clinicopathological features of HER2-low expressed advanced gastric cancers.
    Nakayama, Izuma
    Takahari, Daisuke
    Chin, Keisho
    Wakatsuki, Takeru
    Ooki, Akira
    Ogura, Mariko
    Fukuda, Koshiro
    Osumi, Hiroki
    Fukuoka, Shota
    Shinozaki, Eiji
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 459 - 459
  • [24] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Mengdi Chen
    Weilin Chen
    Deyue Liu
    Weiguo Chen
    Kunwei Shen
    Jiayi Wu
    Li Zhu
    Breast Cancer, 2022, 29 : 844 - 853
  • [25] The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer
    Park, Woong Ki
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jonghan
    Lee, Se Kyung
    Ryu, Jai Min
    Chae, Byung Joo
    CANCERS, 2024, 16 (14)
  • [26] Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer
    Shang, Jiuyan
    Sun, Xuemei
    Xu, Zihang
    Cai, Lijing
    Liu, Chang
    Wu, Si
    Liu, Yueping
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer
    Chen, Mengdi
    Chen, Weilin
    Liu, Deyue
    Chen, Weiguo
    Shen, Kunwei
    Wu, Jiayi
    Zhu, Li
    BREAST CANCER, 2022, 29 (05) : 844 - 853
  • [28] Prognostic value of HER2-low expression according to hormone receptor status in breast cancer patients
    Huszno, J.
    Kolosza, Z.
    Stobiecka, E.
    Ponikiewska, D.
    Szczesniak, B.
    Simek, J.
    Chmielik, E.
    BREAST, 2025, 80
  • [29] Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis
    Molinelli, C.
    Jacobs, F.
    Agostinetto, E.
    Nader-Marta, G.
    Ceppi, M.
    Bruzzone, M.
    Blondeaux, E.
    Schettini, F.
    Prat, A.
    Viale, G.
    Del Mastro, L.
    Lambertini, M.
    de Azambuja, E.
    ESMO OPEN, 2023, 8 (04)
  • [30] Biologic and prognostic significance of HER2-low and ER-low expressions in de novo metastatic breast cancer
    Ren, Chongxi
    Sun, Jianna
    Kong, Lingjun
    Yang, Yunmei
    Liu, Jiabin
    Zhou, Tong
    Yin, Ruisheng
    Li, Fengying
    Wang, Xin
    Wang, Hongqiao
    Gu, Xiaoying
    Li, Sheng
    Ren, Haixia
    Yu, Hongjun
    Di, Shuping
    Zhao, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345